This live activity will cover early detection and intervention in cancer.

This live activity will cover early detection and intervention in cancer.

This activity will cover the treatment and management of patients with bladder cancer.

This program targets healthcare gaps related to the treatment and management of atrial fibrillation (AF), impacting outcomes through guidelines and best practices, appropriate antiarrhythmic use and shared decision-making.

This live activity will cover early detection and intervention in cancer.

This live, case‐based activity targets health care gaps related to the underlying autoimmune causes of alopecia areata (AA) and targeted treatment approaches, which can have a profound impact on health‐related quality of life through burden of disease and associated comorbidities.

This activity will cover the treatment and management of patients with bladder cancer.

This live, case-based activity will explore the role of screening and surveillance for patients with esophageal cancer (EC) and review clinical trial data on the efficacy and safety of immune checkpoint inhibitors as adjuvant treatment and across lines of therapy.

This live activity will cover early detection and intervention in cancer.

This live, case-based activity will explore the role of screening and surveillance for patients with esophageal cancer (EC) and review clinical trial data on the efficacy and safety of immune checkpoint inhibitors as adjuvant treatment and across lines of therapy.

The COVID-19 FRONTLINE Grand Rounds series provides a comprehensive and up-to-date perspective on the ever-changing management of patients with COVID-19. Each Grand Rounds session features in-depth case studies to encourage retention of the lessons and provide new perspectives on the management of patients during the COVID-19 pandemic. This program will focus on optimizing outcomes for hospitalized and nonhospitalized patients with COVID-19 through the use of novel agents authorized for emergency use.

This activity will cover the treatment and management of patients with psoriatic arthritis during the COVID-19 pandemic.